Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Crispr Therapeutics Ag (CRSP)  
$36.29 0.49 (1.33%) as of 4:30 Fri 5/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 70,650,000
Market Cap: 2.56(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $31.27 - $65.26
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    : 8.9
Insider 3/6 Months : 9.5
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   CRISPR Therapeutics is a gene editing company focused on the development of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) based therapeutics. CRISPR/Cas9 is a technology for gene editing, the process of altering specific sequences of genomic DNA. Co. is developing several gene-edited allogeneic cell therapy programs. Co.'s main product candidate, CTX001, is an investigational ex vivo CRISPR gene-edited therapy that is being evaluated for patients suffering from transfusion-dependent beta thalassemia or severe sickle cell disease in which a patient's hematopoietic stem cells are engineered to produce fetal hemoglobin in red blood cells.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 7,000 7,000 7,000
Total Buy Value $0 $313,948 $313,948 $313,948
Total People Bought 0 1 1 1
Total Buy Transactions 0 1 1 1
Total Shares Sold 44,610 108,413 147,161 306,882
Total Sell Value $1,849,355 $5,333,139 $7,439,695 $18,274,208
Total People Sold 5 5 5 5
Total Sell Transactions 12 19 23 35
End Date 2025-03-04 2024-12-01 2024-06-02 2023-06-03

   
Records found: 530
  Page 1 of 22  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Patel Naimish Chief Medical Officer   •       –      –    2025-05-29 4 S $35.94 $141,316 D/D (3,932) 6,068     -
   Patel Naimish Chief Medical Officer   •       –      –    2025-05-28 4 OE $0.00 $0 D/D 10,000 10,000     -
   Kasinger James R. General Counsel and Secretary   •       –      –    2025-03-21 4 S $41.23 $131,318 D/D (3,185) 81,729 11%     
   Bruno Julianne Chief Operating Officer   •       –      –    2025-03-21 4 S $41.23 $70,668 D/D (1,714) 10,544 11%     
   Prasad Raju Chief Financial Officer   •       –      –    2025-03-21 4 S $41.23 $90,582 D/D (2,197) 16,767 11%     
   Kulkarni Samarth Chief Executive Officer   •       •      –    2025-03-21 4 S $41.23 $413,578 D/D (10,031) 195,085 11%     
   Kasinger James R. General Counsel and Secretary   •       –      –    2025-03-20 4 OE $0.00 $0 D/D 6,250 84,914     -
   Bruno Julianne Chief Operating Officer   •       –      –    2025-03-20 4 OE $0.00 $0 D/D 3,750 12,258     -
   Prasad Raju Chief Financial Officer   •       –      –    2025-03-20 4 OE $0.00 $0 D/D 6,250 18,964     -
   Kulkarni Samarth Chief Executive Officer   •       •      –    2025-03-20 4 OE $0.00 $0 D/D 19,688 205,116     -
   Prasad Raju Chief Financial Officer   •       –      –    2025-03-17 4 S $41.80 $157,252 D/D (3,762) 12,714 14%     
   Prasad Raju Chief Financial Officer   •       –      –    2025-03-14 4 OE $0.00 $0 D/D 10,000 16,476     -
   Kasinger James R. General Counsel and Secretary   •       –      –    2025-03-12 4 S $43.32 $48,345 D/D (1,116) 78,664 15%     
   Kulkarni Samarth Chief Executive Officer   •       •      –    2025-03-12 4 S $43.32 $193,294 D/D (4,462) 185,428 15%     
   Bruno Julianne Chief Operating Officer   •       –      –    2025-03-12 4 S $43.32 $8,231 D/D (190) 8,508 15%     
   Kasinger James R. General Counsel and Secretary   •       –      –    2025-03-11 4 OE $0.00 $0 D/D 2,250 79,780     -
   Kasinger James R. General Counsel and Secretary   •       –      –    2025-03-11 4 S $42.42 $120,897 D/D (2,850) 77,530 13%     
   Kulkarni Samarth Chief Executive Officer   •       •      –    2025-03-11 4 OE $0.00 $0 D/D 9,000 189,890     -
   Kulkarni Samarth Chief Executive Officer   •       •      –    2025-03-11 4 S $42.42 $423,055 D/D (9,973) 180,890 13%     
   Bruno Julianne Chief Operating Officer   •       –      –    2025-03-11 4 OE $0.00 $0 D/D 435 8,698     -
   Bruno Julianne Chief Operating Officer   •       –      –    2025-03-11 4 S $42.42 $50,819 D/D (1,198) 8,263 13%     
   Kasinger James R. General Counsel and Secretary   •       –      –    2025-03-10 4 OE $0.00 $0 D/D 5,500 80,380     -
   Kulkarni Samarth Chief Executive Officer   •       •      –    2025-03-10 4 OE $0.00 $0 D/D 19,250 190,863     -
   Bruno Julianne Chief Operating Officer   •       –      –    2025-03-10 4 OE $0.00 $0 D/D 2,399 9,461     -
   Greene John   –       •      –    2025-02-26 4 B $44.85 $313,948 D/D 7,000 7,000 0.01 -17%     
  530 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 22
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us